Role of lenalidomide in the management of myelodysplastic syndromes with del(5q) associated with pure red cell aplasia (PRCA)

Annals of Hematology

Volumn 94, Issue 3, 2015, Pages 531-534

  Cerchione, Claudio ^a   Catalano, Lucio ^a   Cerciello, Giuseppe ^a   Avilia, Simona ^a   Picardi, Marco ^a   Risitano, Antonio Maria ^a   Pisano, Ida ^a   Alfinito, Fiorella ^a   Pane, Fabrizio ^a  

^a FEDERICO II UNIVERSITY HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LENALIDOMIDE; THALIDOMIDE;

ADULT; AGED; ANALOGS AND DERIVATIVES; CASE REPORT; CHROMOSOME 5; CHROMOSOME DELETION; COMPLICATION; FEMALE; GENETICS; HUMAN; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; RED-CELL APLASIA, PURE;

ADULT; AGED; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 5; FEMALE; HUMANS; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; RED-CELL APLASIA, PURE; THALIDOMIDE;

EID: 84927565324     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-014-2192-z     Document Type: Letter

References (10)

1. Tefferi A et al (2009) Myelodysplastic syndromes. N Engl J Med 361:1872–1885
2. Fisch P et al (2000) Pure red cell aplasia. Br J Haematol 111:1010–1022
3. Ammus SS et al (1987) Acquired pure red cell aplasia. Am J Hematol 24:311–326
4. Sawada K et al (2008) Acquired pure red cell aplasia: updated review of treatment. Br J Haematol 142(4):505–14
5. Williamson PJ et al (1991) Red cell aplasia in myelodysplastic syndrome. J Clin Pathol 44:431–432
6. Garcia-Suarez J et al (1998) Myelodysplastic syndrome with erythroid hypoplasia/aplasia: a case report and review of the literature. Am J Hematol 58:316–325
7. Abkhowitz JL et al (1986) Pure red cell aplasia: lymphocyte inhibition of erythropoiesis. Br J Heamatol 63:59–62
8. Biesma DH et al (1997) Immunosuppressive therapy for hypoplastic myelodysplastic syndrome. Cancer 79:1548–1551
9. Kim H et al (2009) A pilot dose-escalating study of alemtuzumab plus cyclosporine for patients with bone marrow failure syndrome. Leuk Res 33(2):222–31
10. List A et al (2006) Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion. N Engl J Med 355(14):1456–65